Theriva Biologics, Inc. (TOVX) › Weighted Average Diluted SharesTheriva Biologics, Inc. (TOVX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 19.01M2021-12-31: 12.19M2022-12-31: 15.33M2023-12-31: 644.3K2024-12-31: 1.35M2025-12-31: 12.14M12.14M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3112.14M+800.6%2026-03-12From 2025-01-012024-12-311.35M+109.2%2026-03-12From 2024-01-012023-12-31644.3K-95.8%2025-03-06From 2023-01-012022-12-3115.33M+25.8%2024-03-25From 2022-01-012021-12-3112.19M-35.9%2023-03-30From 2021-01-012020-12-3119.01M—2022-03-16From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)